Hyperaldosteronism: Clinical Trials

8 trials for Hyperaldosteronism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 8
Phase 31Completed 1

Follow Hyperaldosteronism: new trials by email Literature Review of Hyperaldosteronism trials Research Report on Hyperaldosteronism

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of CIN-107 in Adults With Primary Aldosteronism
CIN-107 2 mg dosing, CIN-107 4 mg dosing, CIN-107 8 mg dosing - Primary Aldosteronism, Hyperaldosteronism
Phase 2CompletedAstraZeneca152021-03-082026-03-03
Calcium Channel Blockade in Primary Aldosteronism
Amlodipine - Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
Phase 2CompletedBrigham and Women's Hospital152020-09-012025-04-15
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours
11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre - Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism
Phase 2 / Phase 3CompletedChangi General Hospital972019-12-302026-10-26
DP13 - A Phase II Study in Patients With Primary Aldosteronism
dexfadrostat phosphate - Primary Aldosteronism
Phase 2CompletedDamian Pharma AG352019-11-212024-11-22
Open-label Study on Treatment of Primary Aldosteronism With Everolimus
Everolimus 0.75 mg - Primary Aldosteronism
Phase 2CompletedUniversity Hospital, Basel, Switzerland122017-05-222019-01-09
Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy
Abiraterone Acetate, Prednisone 5 mg twice daily, Prednisone 5 mg once daily - Prostate Cancer
Phase 2CompletedJanssen Pharmaceutica N.V., Belgium1642013-07-162019-07-05
The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
Eplerenone, Amlodipine, Microneurography - Hypertension
Phase 2CompletedUniversity of Texas Southwestern Medical Center142013-07-012022-03-18
Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism
LCI699 - Primary Hyperaldosteronism
Phase 2CompletedNovartis122008-06-012009-08-26

Narrower conditions

Hypertension (2)  ·  Adrenal Gland Neoplasms (1)  ·  Hypokalemia (1)  ·  Neoplasm Metastasis (1)  ·  Prostatic Neoplasms (1)

Broader conditions

Adrenal Gland Diseases (8)  ·  Adrenocortical Hyperfunction (8)  ·  Endocrine System Diseases (8)  ·  Cardiovascular Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Vascular Diseases (2)  ·  Endocrine Gland Neoplasms (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Neoplastic Processes (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Amlodipine (2)  ·  Abiraterone Acetate (1)  ·  Dexamethasone (1)  ·  Eplerenone (1)  ·  Everolimus (1)  ·  Osilodrostat (1)  ·  Prednisone (1)

Sponsors

AstraZeneca (1)  ·  Brigham and Women's Hospital (1)  ·  Changi General Hospital (1)  ·  Damian Pharma AG (1)  ·  Janssen Pharmaceutica N.V., Belgium (1)  ·  Novartis (1)  ·  University Hospital, Basel, Switzerland (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (3)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Singapore (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Anand Vaidya, MD (1)  ·  Marc Y Donath, Prof. (1)  ·  Paolo Mulatero, Prof (1)  ·  Wanpen Vongpatanasin, MD (1)

Results publications

PMID 20837883, PMID 24107737, PMID 31246234, PMID 32923850, PMID 33794293, PMID 37490693